Title |
Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis
|
---|---|
Published in |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, November 2022
|
DOI | 10.2147/dmso.s390075 |
Pubmed ID | |
Authors |
Gian Paolo Fadini, Cristobal Morales, Irene Caballero, Beatriz González, Nikolaos Tentolouris, Agostino Consoli |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 7 | 70% |
Paraguay | 1 | 10% |
United States | 1 | 10% |
Unknown | 1 | 10% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 50% |
Practitioners (doctors, other healthcare professionals) | 4 | 40% |
Scientists | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 8 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 1 | 13% |
Lecturer > Senior Lecturer | 1 | 13% |
Student > Master | 1 | 13% |
Unknown | 5 | 63% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 38% |
Biochemistry, Genetics and Molecular Biology | 1 | 13% |
Unknown | 4 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2022.
All research outputs
#6,536,378
of 25,732,188 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#268
of 1,190 outputs
Outputs of similar age
#115,596
of 442,536 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#5
of 46 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,190 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,536 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.